Also on hold is an approval application for Watson's branded antidiabetic, Actos (pioglitazone hydrochloride) plus MET (metformin) XR. ...
On June 18, 2007, the first generic formulation of cefepime hydrochloride was approved by the US Food and Drug Administration (FDA). ...
On June 18, 2007, the first generic formulation of cefepime hydrochloride was approved by the US Food and Drug Administration (FDA). ...
(Apotex) stating that Apotex intends to enter the US market with Apotex's cefepime hydrochloride upon receiving approval from the US Food and Drug ...